For example, it has been reported that levels of prostate-specific antigen (PSA), a biomarker widely used to screen men for prostate cancer, tend to increase with age.14 With this finding, age-adjusted PSA would provide a more accurate screening tool for prostate cancer, particularly in older populations. This evidence concerns the gene KLK3 and prostate carcinoma.